Volume 26, Issue 130, December 2022

Expectant versus aggressive management of severe preeclampsia at 24-34 weeks of gestation

Sarah M Ghazali^1♦, Ohoud A AlGhamdi², Nora N Sahly¹, Kholoud K Nagadi², Reem M Khalifah², Sedrah M Hanbazaza², Danah I Krimli², Sarah M Allaf², Renad A Turkistani², Haifa'a A Mansouri¹

¹Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah, Saudi Arabia
²Medical intern, King Abdulaziz University Faculty of Medicine, Jeddah, Saudi Arabia

^♦Corresponding author
Sarah M. Ghazali Department of Obstetrics and Gynecology, King Abdulaziz University

ABSTRACT

Background: Preeclampsia is characterized by the onset of hypertension beyond 20 weeks of pregnancy, in addition to proteinuria and/or end-organ dysfunction, including high liver enzymes, elevated serum creatinine, thrombocytopenia, pulmonary edema, new-onset headache not responding to medications and visual disturbances. The study aimed to assess maternal and perinatal outcomes between expectant (delivery 48 h after admission) and aggressive management (delivery within 48 h) in patients with preeclampsia according to the newly defined 2020 American College of Obstetrics and Gynecology preeclampsia guideline to determine the optimal management approach.

Keywords: preeclampsia, aggressive management, preterm delivery, expectant management

Medical Science, 2022, 26, ms565e2659

PDF

DOI: https://doi.org/10.54905/disssi/v26i130/ms565e2659

Published: 26 December 2022